Add BrightSurf on Google Email

Boston University School of Medicine


Female hormone supplements with estrogen and progestin linked to breast cancer risk

Postmenopausal African American women who use female hormone supplements containing estrogen and progestin are at a 50% increased risk of estrogen receptor positive breast cancer. The study found greater increases in risk for recent and long-term users, highlighting the importance of limiting combination therapy.

SourceBoston University School of Medicine·JournalJNCI Journal of the National Cancer Institute·DateNov 30, 2015

Time to reassess blood-pressure goals

Recent SPRINT trial results suggest lowering systolic blood pressure below 120 may be associated with a lower incidence of cardiovascular disease and reduced mortality by 25%. The study's findings, published in the New England Journal of Medicine, may lead to a reevaluation of blood pressure goals for non-diabetic individuals over 50

SourceBoston University School of Medicine·JournalNew England Journal of Medicine·DateNov 9, 2015

BMC reduces emergency wait time, improves care for pediatric sickle cell disease patients

Boston Medical Center (BMC) has significantly reduced the average wait time for pediatric patients experiencing severe pain from sickle cell disease from 56 minutes to 23 minutes. The hospital's quality improvement initiative also improved care by reducing the time to administer pain medication and increase patient-controlled analgesics.

Study: Physician-patient decision making may differ in care of racial/ethnic minorities

A new study published in Patient Education and Counseling found that patients of minority race/ethnicity groups receive less information from their doctors about treatment rationale and scientific research. The study emphasizes the importance of consistent physician-patient communication to ensure equal care for all patients.

SourceBoston University School of Medicine·JournalPatient Education and Counseling·DateSep 9, 2015

No link found between PTSD and cancer risk

Researchers from Boston University School of Medicine find no evidence of association between Post Traumatic Stress Disorder (PTSD) and cancer incidence. The large population sample analyzed various cancer diagnoses among people with PTSD compared to the general population, showing no strong associations even among select groups.

SourceBoston University School of Medicine·JournalEuropean Journal of Epidemiology·DateAug 14, 2015

Education intervention with residents improves understanding of transgender issues

A study led by Boston University School of Medicine researchers found that educating medical residents about transgender identity improved their knowledge and willingness to assist with hormonal therapy. The intervention increased residents' willingness to provide care for transgender patients from 5% to 76% for female-to-male patients...

SourceBoston University School of Medicine·JournalEndocrine Practice·DateAug 10, 2015

Researchers identify new cancer marker and possible therapeutic target for breast cancer

Researchers at Boston University School of Medicine have identified a new molecule named IL13RA2 as a potential marker for metastatic basal-like breast cancer (BLBC). The discovery suggests that targeting this molecule could slow tumor growth and spread, offering a glimmer of hope for patients with this aggressive form of breast cancer.

SourceBoston University School of Medicine·JournalBreast Cancer Research·DateJul 31, 2015

Rates of drunk driving tied to state alcohol policies, BU study finds

A new study by Boston University researchers found that states with more restrictive alcohol policies and regulations have lower rates of self-reported drunk driving. The study also suggests that laws targeting binge drinking are equally effective in preventing drunk driving as those specifically targeting impaired driving.

SourceBoston University School of Medicine·JournalThe International Journal of Alcohol and Drug Research·DateJul 15, 2015

ED worsened, testosterone levels decreased by some treatments of prostate enlargement

Researchers found that finasteride treatment led to a marked decline in erectile function and testosterone levels, while tamsulosin therapy showed no adverse effects. The study highlights the need for careful consideration of sexual side effects when treating benign prostate enlargement with 5α reductase inhibitors.

SourceBoston University School of Medicine·JournalHormone Molecular Biology and Clinical Investigation·DateJun 12, 2015